Authors’ response to comment on “Second‐line pharmacological treatment strategies for trigeminal neuralgia: A retrospective comparison of lacosamide, gabapentin, and baclofen”

This is the authors' abstract. We don't add key points for this paper.

A retrospective comparison of lacosamide, gabapentin, and baclofen"We thank the authors for their interest in our work and for the thoughtful and constructive critique of our studies on lacosamide (LCM) in refractory trigeminal neuralgia (TN).1,2 The comment raises important considerations regarding the methodological limitations and generalizability of our findings, which we fully acknowledge.